COMPANY BACKGROUND
Akero Therapeutics, a Novo Nordisk company, is a clinical stage biopharmaceutical company focused on discovering and developing transformational treatments for patients with serious metabolic diseases marked by high unmet need. Our current focus is on advancing our lead program efruxifermin (EFX) to provide a powerful new treatment for patients with MASH(metabolic dysfunction-associated steatohepatitis).
We are a team of problem solvers dedicated to pursuing bold scientific approaches to build a brighter future for patients. Our diverse skill sets and backgrounds, desire to learn from each other and collaborative spirit breed a culture where everyone feels inspired to bring their best thinking to work, and to bring out the best in others.
Job Summary
The Principal Scientist supports analytical development and characterization activities for late-stage biologic development leading to licensure application submission. The successful candidate will work closely with cross-functional teams across CMC to take a leading role in analytical characterization activities in support of comparability studies, heightened characterization studies, method development, control strategy development, CQA risk assessment, and other late-stage biologic development activities relating to analytical development. This position involves authoring and reviewing of technical reports needed for regulatory filings and participation in the drafting of regulatory documents, including IND/IMPD/BLA.
The successful candidate is expected to have a strong technical expertise in analytical characterization for protein biologics development. This position requires a knowledge of key state of art heightened characterization methodologies and their applications for protein pharmaceutics.
Relationships:
This position will report to the Director, Analytical Development, CMC or VP, Analytical Science and Quality Control.
The position will interact with all areas of CMC. In addition, CMC within Novo Nordisk. The position interacts with team members at the IC through Vice President level. The position requires experience interacting with senior level positions in each of these departments and a good understanding of how these peer teams operate, ideally through experience working within these teams (broad experience).
Externally, the position will engage with CDMOs.
Job Responsibilities
Physical Requirement: Ability to travel up to 15%. Internationally and Domestic
Qualifications
The base compensation range for this position is $152,700 to $218,128. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance.
Akero Therapeutics, a Novo Nordisk company, offers long-term incentive compensation depending on the position's level or other company factors.
Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.
The job posting is anticipated to close on April 10th. The Company may however extend this time-period, in which case the posting will remain available on our careers website at https://akerotx.com/job-opportunities.
EEO Statement:
Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

Morgan Stanley

Edges Wellness Center LLC

WSP in Canada

Digitalenta

Cox Automotive Inc.

Akero Therapeutics

Akero Therapeutics

Akero Therapeutics